InvestSMART

EMvision Medical Devices Limited (ASX: EMV) - Announcements

Current share price for EMV : $1.670 0.055 (3.19%)+

ASX company news and announcements for EMvision Medical Devices Limited (EMV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EMvision Medical Devices Limited (EMV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EMvision Medical Devices Limited (EMV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EMvision Medical Devices Limited (EMV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$155 Appendix 3G 6 May 2021 9:33AM $3.200 $1.670 fallen by 47.81%
$155 Appendix 4C - quarterly 30 Apr 2021 9:15AM $3.230 $1.670 fallen by 48.30%
$155 Breakthroughs in Technology & Product Development 28 Apr 2021 8:41AM $3.030 $1.670 fallen by 44.88%
$155 Change of Director's Interest Notice 15 Apr 2021 9:49AM $2.840 $1.670 fallen by 41.20%
$155 EMVision presents at ASX Small and Mid-Cap Conference 17 Mar 2021 9:21AM $2.700 $1.670 fallen by 38.15%
$155 S&P DJI Announces March 2021 Quarterly Rebalance 12 Mar 2021 5:02PM $2.660 $1.670 fallen by 37.22%
$155 Successful MRFF Bid 2 Mar 2021 9:30AM $2.420 $1.670 fallen by 30.99%
$155 Trading Halt 26 Feb 2021 9:41AM $2.420 $1.670 fallen by 30.99%
$155 Half Year Report & CEO Update 25 Feb 2021 9:47AM $2.340 $1.670 fallen by 28.63%
$155 Appendix 4C - quarterly 29 Jan 2021 8:10AM $2.740 $1.670 fallen by 39.05%
$155 FDA Provides De Novo Guidance 25 Jan 2021 8:19AM $2.880 $1.670 fallen by 42.01%
$155 Australian Stroke Alliance & FDA Update 21 Dec 2020 9:15AM $3.100 $1.670 fallen by 46.13%
$155 Change of Principal Place of Business 21 Dec 2020 9:12AM $3.100 $1.670 fallen by 46.13%
$155 Prof Stuart Crozier Appointed as Chief Scientific Officer 17 Dec 2020 9:45AM $3.030 $1.670 fallen by 44.88%
$155 Substantial Shareholder Update 17 Dec 2020 9:38AM $3.030 $1.670 fallen by 44.88%
$155 Ceasing to be a substantial holder 17 Dec 2020 9:37AM $3.030 $1.670 fallen by 44.88%
$155 Appendix 2A - Exercise of Options 17 Dec 2020 9:35AM $3.030 $1.670 fallen by 44.88%
$155 EMVision Receives $1.28M R&D Tax Incentive Rebate for FY20 14 Dec 2020 8:22AM $2.850 $1.670 fallen by 41.40%
$155 Appendix 2A - Exercise of Options 14 Dec 2020 8:21AM $2.850 $1.670 fallen by 41.40%
$155 Appendix 2A - Release of Restricted Securities 14 Dec 2020 8:21AM $2.850 $1.670 fallen by 41.40%
$155 Change of Director's Interest Notice - Correction 14 Dec 2020 8:21AM $2.850 $1.670 fallen by 41.40%
$155 Change of Director's Interest Notice 7 Dec 2020 8:23AM $3.450 $1.670 fallen by 51.59%
$155 Change of Director's Interest Notice 7 Dec 2020 8:23AM $3.450 $1.670 fallen by 51.59%
$155 Appendix 3G - Issue of Options 7 Dec 2020 8:23AM $3.450 $1.670 fallen by 51.59%
$155 Release of Restricted Securities from Escrow 7 Dec 2020 8:23AM $3.450 $1.670 fallen by 51.59%

251 - 275 of 375 results

Page 11 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.